Sternal Closure Devices - Market Insights, Competitive Landscape, and Market Forecast - 2034

Sternal Closure Devices Market Summary

Overview:

• The Sternal Closure Devices market is estimated at USD 2.35 billion in 2025 and is projected to reach USD 3.97 billion by 2034. Growth is anchored in the rising burden of cardiovascular disease, sustained volumes of sternotomy-based cardiac surgery, and the shift from conventional wire closure toward rigid plate and screw fixation.
• The global Sternal Closure Devices market is growing at a CAGR of 6.0% during the forecast period from 2026 to 2034.
• By product type, the sternal closure wires segment dominated the Sternal Closure Devices market with a 46% share in 2025.
• By application, the cardiology segment dominated the Sternal Closure Devices market with a 74% share in 2025.
• By end-user, the hospitals & clinics segment dominated the Sternal Closure Devices market with a 79% share in 2025.
• North America dominated the global Sternal Closure Devices market revenue with a 44% share in 2025, representing the highest regional market share globally.

A sternal closure device is a surgical implant used to re-approximate, stabilize, and fixate the sternum (breastbone) after a median sternotomy or hemisternotomy, and to repair sternal fractures and support chest wall reconstruction. Following open-heart procedures such as coronary artery bypass grafting (CABG) and heart valve surgery, the divided sternum must remain stable to heal; inadequate fixation can lead to sternal dehiscence, non-union, and deep sternal wound infection, which increase mortality, length of stay, and cost. Sternal closure devices include wires, screws, plates, clamps, and cables manufactured from titanium, stainless steel, PEEK, and emerging bioabsorbable materials. The market is organized by product type, spanning sternal closure wires, screws, plates, clamps, and others; by application across cardiology, orthopedics, and respiratory care; by end-user across hospitals and clinics, ambulatory surgical centers, and others; and by geography. Driven by the rising burden of cardiovascular disease, the shift from conventional wire cerclage toward rigid plate fixation, and continuous innovation in low-profile and minimally invasive-compatible implants, sternal closure devices have become a critical component of the cardiothoracic surgical toolkit.

Sternal Closure Devices Market Key Growth Drivers

• The rising global burden of cardiovascular disease, which the World Health Organization identifies as the leading cause of death worldwide, is sustaining high volumes of CABG and valve surgeries that require sternotomy and reliable sternal closure.
• A growing elderly population with comorbidities such as diabetes, obesity, osteoporosis, and chronic obstructive pulmonary disease is increasing the share of high-risk sternotomy patients who benefit from enhanced fixation.
• Surgeons and hospitals are increasingly shifting from conventional stainless steel wire cerclage toward rigid plate and screw fixation to reduce sternal dehiscence, non-union, and deep sternal wound infection.
• Advances in low-profile titanium plates, minimally invasive cardiac surgery-compatible designs, and emerging bioabsorbable and antimicrobial technologies are expanding the use of premium closure systems.
• Product launches and training initiatives, including KLS Martin Group's January 2025 low-profile titanium plating launch and Medtronic's April 2025 partnership with the Society of Thoracic Surgeons, are accelerating adoption of rigid fixation.
• Rising healthcare expenditure, improving reimbursement in developed markets, and expanding cardiac surgery capacity in Asia-Pacific are broadening patient access to sternotomy-based procedures.
• The convergence of cardiovascular disease burden, aging demographics, rigid fixation adoption, and continued implant innovation is expected to sustain steady mid-single-digit growth in the market through 2034.

Key Companies in Sternal Closure Devices Market

The competitive landscape is led by the following active manufacturers:

• Zimmer Biomet
• KLS Martin Group
• Stryker
• Acumed LLC
• Crown Holdco One, Inc.
• B. Braun SE
• JEIL Medical Corporation
• Johnson & Johnson Services, Inc.
• IDEAR S.R.L
• Medtronic

Factors Contributing to the Growth of the Sternal Closure Devices Market

Market Drivers

Rising Burden of Cardiovascular Disease and Open-Heart Surgery Volumes

The most important driver of the Sternal Closure Devices market is the persistent global burden of cardiovascular disease. The World Health Organization identifies cardiovascular disease as the leading cause of death worldwide, accounting for more than 17 million deaths annually. A large share of patients with advanced coronary artery disease and valvular disease require open-heart procedures, including coronary artery bypass grafting and valve replacement, that are performed through a median sternotomy. Every sternotomy must be followed by secure sternal re-approximation so that the bone can heal and the patient can recover and mobilize safely. Because sternal closure is a mandatory step of every such procedure, device demand is closely tied to cardiac surgical volumes. As cardiovascular disease prevalence rises, particularly in aging and emerging populations, demand for wires, plates, screws, and clamps expands directly, anchoring market growth through 2034.

Aging Population and High-Risk Patient Profiles

Population aging is expanding the pool of patients who undergo cardiac and thoracic surgery and who carry elevated risk of sternal complications. Older patients and those with diabetes, obesity, osteoporosis, or chronic obstructive pulmonary disease face higher rates of sternal dehiscence, delayed healing, and deep sternal wound infection, complications that prolong hospitalization, require reoperation, and increase mortality and cost. Because these risk factors are increasingly common among cardiac surgery candidates, surgeons are more likely to select enhanced fixation to protect against failure of closure. This demographic shift raises both the volume of procedures and the proportion of cases in which premium, higher-value closure systems are chosen, supporting revenue growth across product types and care settings throughout the forecast period.

Market Restraints

Despite steady momentum, the Sternal Closure Devices market faces material constraints. The higher cost of rigid plate and screw systems relative to conventional wires is a significant barrier, particularly in price-sensitive and emerging markets and in hospitals operating under tight budgets and group purchasing pressure. Procedural risks, including infection, sternal dehiscence, and non-union, can persist even with advanced devices and may deter some institutions from changing established practice. The growing use of minimally invasive and transcatheter approaches, such as transcatheter valve replacement and percutaneous coronary intervention, can reduce the number of open-heart procedures that require sternotomy. A shortage of surgeons trained in advanced rigid fixation techniques, the learning curve for new implants, and the need for specialized instrumentation constrain adoption. Reimbursement often does not distinguish between wire and rigid fixation, limiting the financial incentive to upgrade, while stringent and evolving regulatory requirements, such as the EU Medical Device Regulation and FDA premarket review, lengthen development timelines and raise compliance costs. Variations in clinical evidence and surgeon preference, together with pricing pressure from hospital purchasing organizations, further temper growth, even as the underlying drivers of cardiovascular disease burden, aging, and rigid fixation adoption remain intact.

Sternal Closure Devices Market Segment Analysis

The Sternal Closure Devices Market is segmented by product type (sternal closure wires, sternal closure screws, sternal closure plates, sternal closure clamps, and others), application (cardiology, orthopedics, and respiratory), end-user (hospitals & clinics, ambulatory surgical centers, and others), and geography (North America, Europe, Asia-Pacific, Rest of World).

By Product Type

Dominant Subsegment: Sternal Closure Wires.

The sternal closure wires segment accounted for 46% of the Sternal Closure Devices market in 2025. Sternal closure wires are the leading product type because stainless steel wire cerclage remains the long-established, most widely used method of closing the sternum after median sternotomy. Wires are inexpensive, familiar to virtually every cardiac surgeon, quick to apply, and compatible with standard operating room workflows, which sustains very high, recurring volumes across hospitals of every size and in price-sensitive markets. Their low cost relative to rigid systems also makes them the default choice in routine, lower-risk CABG and valve procedures. While sternal closure plates and screws are the fastest-growing product types as surgeons adopt rigid fixation for high-risk patients and minimally invasive cases, and clamps and other devices serve specific niches, the sheer procedure volume, affordability, and clinical familiarity of wires secure the segment's leadership across the forecast period.

By Application

Dominant Subsegment: Cardiology.

The cardiology segment accounted for 74% of the Sternal Closure Devices market in 2025. Cardiology is the leading application because the great majority of sternal closures follow median sternotomy performed for cardiac surgery, principally coronary artery bypass grafting, heart valve repair and replacement, and aortic procedures. The high and recurring volume of these operations, driven by the global burden of coronary and valvular disease, creates a large and dependable base of demand for closure devices. Cardiac surgeons also face the greatest clinical consequences of sternal complications, including deep sternal wound infection and mediastinitis, which strengthens interest in rigid fixation for high-risk patients. Orthopedics, covering sternal fracture fixation and chest wall reconstruction after trauma, and respiratory applications, spanning thoracic surgery, represent smaller but steadily growing uses. Nonetheless, the scale and recurrence of cardiac surgery secure cardiology's leadership across the forecast period.

Sternal Closure Devices Market Region Analysis

Dominant Region: North America

North America accounted for 44% of the global Sternal Closure Devices market revenue in 2025, representing the highest regional market share globally. The region's dominance reflects a high burden of cardiovascular disease, large volumes of CABG and valve surgery, advanced hospital infrastructure, favorable reimbursement, and early adoption of rigid sternal fixation, particularly in the United States. North America is home to leading manufacturers including Zimmer Biomet, Stryker, Medtronic, and Johnson & Johnson, which maintain extensive surgeon training programs and distribution networks. Initiatives such as Medtronic's April 2025 partnership with the Society of Thoracic Surgeons to standardize sternotomy closure protocols in 500 US teaching hospitals reinforce advanced-fixation adoption. Strong clinical evidence generation, quality programs targeting surgical-site infection, and established FDA regulatory pathways anchor the region's continued leadership across the forecast period.

Fastest Growing Region: Asia-Pacific

Asia-Pacific is the fastest-growing region in the Sternal Closure Devices market. The region's elevated CAGR is driven by a rising burden of cardiovascular disease, an aging population, expanding cardiac surgery capacity, and growing healthcare investment across China, Japan, India, South Korea, and Australia. China and India are adding cardiac centers and surgeon training capacity, Japan has a mature, aging patient base, South Korea hosts domestic manufacturers such as JEIL Medical Corporation, and Australia offers advanced clinical infrastructure. Rising insurance coverage and increasing procedure volumes are accelerating the transition from basic wires toward rigid fixation systems, while global manufacturers expand local distribution and training. The combination of disease burden, infrastructure build-out, and rising adoption positions Asia-Pacific as the principal source of incremental growth over the forecast period.

Regional Commentary

North America

North America accounted for 44% of the global Sternal Closure Devices market revenue in 2025. The United States dominates on the strength of its cardiac surgery volumes, advanced hospital infrastructure, favorable reimbursement, and the presence of leading manufacturers, while rigid fixation adoption, surgeon training initiatives, and quality programs targeting surgical-site infection reinforce its leadership.

Europe

Europe is a large and advanced regional market, supported by established cardiac surgery programs, broad health coverage, and a strong medical-device manufacturing base, including Germany-based KLS Martin Group and B. Braun SE. The EU Medical Device Regulation sets rigorous clinical-evidence and quality requirements that favor established manufacturers. Demand across Germany, France, the United Kingdom, Italy, and Spain is supported by high cardiac surgery volumes, an aging population, and growing adoption of rigid plate fixation in high-risk patients.

Asia-Pacific

Asia-Pacific is the fastest-growing region, propelled by a rising cardiovascular disease burden, expanding cardiac surgery capacity, and growing healthcare investment across China, Japan, India, South Korea, and Australia. Cardiac center build-out in China and India, an aging patient base in Japan, domestic manufacturing in South Korea, and advanced clinical infrastructure in Australia are accelerating regional demand and the transition toward rigid fixation.

Rest of World

The Rest of World region, spanning Latin America, the Middle East, and Africa, is an emerging growth frontier. Expanding cardiac surgery programs and healthcare infrastructure, rising cardiovascular disease prevalence, and efforts to broaden access to open-heart surgery are gradually increasing demand for sternal closure devices, while international partnerships and distributor networks support the build-out of regional supply.

Sternal Closure Devices Market Competitive Landscape

The Sternal Closure Devices market is classified as Moderately Concentrated. A group of diversified orthopedic and medical technology leaders with broad portfolios and global distribution, including Zimmer Biomet, KLS Martin Group, Johnson & Johnson Services, Stryker, and Medtronic, anchors the top tier, while specialized and regional manufacturers such as Acumed, B. Braun, JEIL Medical Corporation, IDEAR S.R.L., and Crown Holdco One compete through focused sternal fixation portfolios, price positioning, and regional strength, intensifying competition in rigid plate fixation.

The competitive landscape can be evaluated across the following dimensions:

• Market concentration: Moderately concentrated, with a few diversified medical technology leaders holding a large share and a field of specialized and regional manufacturers competing in plates, screws, and clamps.
• Leading players: Zimmer Biomet, KLS Martin Group, Johnson & Johnson Services, Stryker, and Medtronic anchor the top tier through broad portfolios, surgeon relationships, and global distribution.
• Geographic reach: Leaders operate global distribution and training networks, while regional players such as JEIL Medical Corporation and IDEAR S.R.L. compete on local presence and price.
• Product portfolio strength: Top players offer wires, cables, plates, screws, and clamps, together with dedicated instrumentation, to serve routine and high-risk sternal closure.
• Materials and design: Titanium, stainless steel, and PEEK implants, low-profile and anatomically contoured plates, and minimally invasive-compatible designs are decisive differentiators.
• Strategic partnerships: Collaboration with professional societies and teaching hospitals, such as Medtronic's April 2025 partnership with the Society of Thoracic Surgeons, extends clinical influence and standardizes practice.
• M&A activity: Portfolio consolidation, notably Zimmer Biomet's USD 250 million acquisition of A&E Medical Corporation in December 2020, has broadened leaders' sternal closure offerings.
• Manufacturing capabilities: Precision machining of titanium and stainless steel implants, quality systems compliant with FDA and EU MDR requirements, and sterile supply logistics are key competitive moats.
• Innovation focus: Rigid plate fixation for high-risk patients, hemisternotomy and minimally invasive solutions, and bioabsorbable and antimicrobial technologies.

Sternal Closure Devices Market Recent Developmental Activities

In April 2025, Medtronic initiated an educational partnership with the Society of Thoracic Surgeons to standardize median sternotomy closure protocols using advanced rigid fixation in 500 US teaching hospitals. Strategic significance: Extends clinical influence and promotes best-practice adoption of rigid sternal fixation in leading cardiac surgery centers.

In March 2025, Zimmer Biomet updated its surgical training programs, focusing on reducing the risk of sternal non-union in high-risk cardiothoracic surgeries. Strategic significance: Reinforces Zimmer Biomet's position in rigid fixation and supports adoption of its sternal closure portfolio among high-risk patients.

Sternal Closure Devices Market Segmentation

Sternal Closure Devices Market by Product Type

• Sternal Closure Wires
• Sternal Closure Screws
• Sternal Closure Plates
• Sternal Closure Clamps
• Others

Sternal Closure Devices Market by Application

• Cardiology
• Orthopedics
• Respiratory

Sternal Closure Devices Market by End-User

• Hospitals & Clinics
• Ambulatory Surgical Centers
• Others

Sternal Closure Devices Market by Geography

• North America Sternal Closure Devices Market
• United States Sternal Closure Devices Market Size in USD million (2023-2034)
• Canada Sternal Closure Devices Market Size in USD million (2023-2034)
• Mexico Sternal Closure Devices Market Size in USD million (2023-2034)
• Europe Sternal Closure Devices Market
• Germany Sternal Closure Devices Market Size in USD million (2023-2034)
• United Kingdom Sternal Closure Devices Market Size in USD million (2023-2034)
• France Sternal Closure Devices Market Size in USD million (2023-2034)
• Italy Sternal Closure Devices Market Size in USD million (2023-2034)
• Spain Sternal Closure Devices Market Size in USD million (2023-2034)
• Rest of Europe Sternal Closure Devices Market Size in USD million (2023-2034)
• Asia-Pacific Sternal Closure Devices Market
• China Sternal Closure Devices Market Size in USD million (2023-2034)
• Japan Sternal Closure Devices Market Size in USD million (2023-2034)
• India Sternal Closure Devices Market Size in USD million (2023-2034)
• Australia Sternal Closure Devices Market Size in USD million (2023-2034)
• South Korea Sternal Closure Devices Market Size in USD million (2023-2034)
• Rest of Asia-Pacific Sternal Closure Devices Market Size in USD million (2023-2034)
• Rest of the World (RoW) Sternal Closure Devices Market
• Middle East Sternal Closure Devices Market Size in USD million (2023-2034)
• Africa Sternal Closure Devices Market Size in USD million (2023-2034)
• South America Sternal Closure Devices Market Size in USD million (2023-2034)

Key Takeaways from the Sternal Closure Devices Market Report Study

• Market size analysis for the current sternal closure devices market size (2025), and market forecast for 9 years (2026 to 2034).
• Top key product/technology developments, mergers, acquisitions, partnerships, and joint ventures that happened over the last 3 years.
• Key companies dominating the global sternal closure devices market.
• Various opportunities available for competitors in the sternal closure devices market space.
• What are the top-performing segments in 2025? How will these segments perform in 2034?
• Which are the top-performing regions and countries in the current sternal closure devices market scenario?
• Which are the regions and countries where companies should concentrate their opportunities for sternal closure devices market growth in the future?

Target audience who can benefit from this sternal closure devices market report study

• Sternal Closure Devices product providers
• Research organizations and consulting companies
• Sternal Closure Devices-related organizations, associations, forums, and other alliances
• Government and corporate offices
• Start-up companies, venture capitalists, and private equity firms
• Distributors and traders dealing in sternal closure devices
• Various end-users who want to know more about the sternal closure devices market and the latest technological developments in the sternal closure devices market.

Frequently Asked Questions:

Q1. What is the growth rate of the Sternal Closure Devices market?

The Sternal Closure Devices market is projected to expand at a CAGR of 6.0% during the forecast period from 2026 to 2034.

Q2. What is the market size of the Sternal Closure Devices market?

The Sternal Closure Devices market is estimated at USD 2.35 billion in 2025 and is projected to reach USD 3.97 billion by 2034.

Q3. Which region dominates the Sternal Closure Devices market?

North America dominated the Sternal Closure Devices market with a 44% share of global revenue in 2025, supported by a high cardiovascular disease burden, large cardiac surgery volumes, advanced hospital infrastructure, favorable reimbursement, early adoption of rigid fixation, and the presence of leading manufacturers. Asia-Pacific is the fastest-growing region over the forecast period.

Q4. What are the key drivers of the Sternal Closure Devices market?

The principal drivers are the rising burden of cardiovascular disease and the resulting volume of sternotomy-based CABG and valve surgeries; an aging population with higher-risk comorbidities; the shift from wire cerclage toward rigid plate and screw fixation; technological advances in titanium, PEEK, bioabsorbable, and antimicrobial implants; rising healthcare expenditure and improving reimbursement; and expanding cardiac surgery capacity in emerging markets.

Q5. Who are the major players in the Sternal Closure Devices market?

The major players include Zimmer Biomet, KLS Martin Group, Stryker, Acumed LLC, Crown Holdco One, Inc., B. Braun SE, JEIL Medical Corporation, Johnson & Johnson Services, Inc., IDEAR S.R.L., and Medtronic, among other active manufacturers profiled in the Competitive Landscape section, along with Arthrex, Inc., Orthofix Medical Inc., and Kinamed Inc. Zimmer Biomet, KLS Martin Group, Johnson & Johnson, Stryker, and Medtronic lead through broad portfolios, surgeon relationships, and global distribution.